CervoMed Inc. — Investor Relations & Filings
Filings indexed
950
across all filing types
Latest filing
2026-05-18
Regulatory Filings
Country
US
United States of America
Listing
US
CRVO
CervoMed Inc. is a clinical-stage biotechnology company that develops treatments for age-related neurologic disorders. The company focuses on neurodegenerative diseases, including Dementia with Lewy Bodies (DLB), Alzheimer's, and Huntington's disease. Its lead investigational candidate is neflamapimod, an orally administered, small molecule brain penetrant that inhibits the p38 alpha protein kinase. CervoMed's scientific approach is based on early intervention to reverse synaptic dysfunction, which is considered a reversible aspect of the neurodegenerative process, before the onset of irreversible nerve cell death. The company is advancing neflamapimod through clinical trials, including a Phase 2 study for patients with DLB.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2026-05-18 | English | |
| FORM 10-Q | 2026-05-15 | English | |
| 8-K - CervoMed Inc. (0001053691) (Filer) | 2026-04-22 | English | |
| 8-K - CervoMed Inc. (0001053691) (Filer) | 2026-03-19 | English | |
| 8-K - CervoMed Inc. (0001053691) (Filer) | 2026-03-17 | English | |
| 8-K - CERVOMED INC. (0001053691) (Filer) | 2026-02-18 | English |
Browse filings by year
24 years- 2026 13 filings
- 2025 60 filings
- 2024 75 filings
- 2023 79 filings
- 2022 67 filings
- 2021 46 filings
- 2020 71 filings
- 2019 64 filings
- 2018 44 filings
- 2017 52 filings
- 2016 70 filings
- 2015 28 filings
- 2014 70 filings
- 2013 32 filings
- 2012 22 filings
- 2011 28 filings
- 2010 18 filings
- 2009 28 filings
- 2008 25 filings
- 2007 5 filings
- 2001 2 filings
- 2000 32 filings
- 1999 12 filings
- 1998 7 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 46468838 | FORM 8-K | 2026-05-18 | English | ||
| 46355067 | FORM 10-Q | 2026-05-15 | English | ||
| 35397934 | 8-K - CervoMed Inc. (0001053691) (Filer) | 2026-04-22 | English | ||
| 32989537 | 8-K - CervoMed Inc. (0001053691) (Filer) | 2026-03-19 | English | ||
| 32967541 | 8-K - CervoMed Inc. (0001053691) (Filer) | 2026-03-17 | English | ||
| 32886393 | 8-K - CERVOMED INC. (0001053691) (Filer) | 2026-02-18 | English | ||
| 32886390 | 4 - CERVOMED INC. (0001053691) (Filer) | 2026-02-13 | English | ||
| 32886388 | 4 - CERVOMED INC. (0001053691) (Filer) | 2026-02-13 | English | ||
| 32886389 | 4 - CERVOMED INC. (0001053691) (Filer) | 2026-02-13 | English | ||
| 32886391 | 4 - CERVOMED INC. (0001053691) (Filer) | 2026-02-13 | English | ||
| 32886392 | 4 - CERVOMED INC. (0001053691) (Filer) | 2026-02-13 | English | ||
| 26854078 | 4 Filing | 2026-02-13 | English | ||
| 26854052 | 8-K Filing | 2026-01-08 | English | ||
|
2025
2 filings
| |||||
| 10998162 | FORM 4 | 2025-12-05 | English | ||
| 10998163 | FORM 3 | 2025-12-05 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Beijing Sun-Novo Pharmaceutical Research Co.,Ltd.
Integrated CRO providing full-spectrum R&D from drug discov…
|
688621 | CN | Professional, scientific and te… |
|
BenevolentAI
Applies artificial intelligence to accelerate drug discover…
|
BAI | LU | Professional, scientific and te… |
|
Berry Genomics Co.,Ltd
Provides clinical genomics and genetic testing for prenatal…
|
000710 | CN | Professional, scientific and te… |
|
BetterLife Pharma
Developing non-hallucinogenic neuroplastogens for severe ne…
|
BETR | CA | Professional, scientific and te… |
|
BGI Genomics Co., Ltd.
Provides integrated solutions for precision medicine via ge…
|
300676 | CN | Professional, scientific and te… |
|
bioAffinity Technologies, Inc.
Develops noninvasive diagnostics and targeted therapeutics …
|
BIAF | US | Professional, scientific and te… |
|
BioArctic
Biopharmaceutical firm developing antibody therapies for ne…
|
BIOA | SE | Professional, scientific and te… |
|
BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD.
Develops antibody therapeutics using proprietary RenMice ge…
|
688796 | CN | Professional, scientific and te… |
|
BIO-GENE TECHNOLOGY LTD
Develops novel insecticides from natural chemistry to comba…
|
BGT | AU | Professional, scientific and te… |
|
BioInfra Co.,Ltd.
Develops multi-biomarker blood tests for early cancer scree…
|
199730 | KR | Professional, scientific and te… |
CervoMed Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34364/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34364 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34364 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34364 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34364}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CervoMed Inc. (id: 34364)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.